PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr1i3
|
ENSMUSG00000005677.15 | Nr1i3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nr1i3 | mm39_v1_chr1_+_171041583_171041612 | 0.51 | 4.2e-06 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_63072367 | 16.67 |
ENSMUST00000030041.5
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr6_-_5256282 | 13.44 |
ENSMUST00000031773.9
|
Pon3
|
paraoxonase 3 |
chr9_+_46179899 | 11.85 |
ENSMUST00000121598.8
|
Apoa5
|
apolipoprotein A-V |
chr10_+_87357657 | 11.74 |
ENSMUST00000020241.17
|
Pah
|
phenylalanine hydroxylase |
chr12_+_8062331 | 11.56 |
ENSMUST00000171239.2
|
Apob
|
apolipoprotein B |
chr4_+_115375461 | 11.38 |
ENSMUST00000058785.10
ENSMUST00000094886.4 |
Cyp4a10
|
cytochrome P450, family 4, subfamily a, polypeptide 10 |
chr6_-_5256225 | 11.19 |
ENSMUST00000125686.8
|
Pon3
|
paraoxonase 3 |
chr10_+_87357782 | 10.93 |
ENSMUST00000219813.2
|
Pah
|
phenylalanine hydroxylase |
chr8_+_120163857 | 10.75 |
ENSMUST00000152420.8
ENSMUST00000212112.2 ENSMUST00000098365.4 |
Osgin1
|
oxidative stress induced growth inhibitor 1 |
chr10_+_80165787 | 10.65 |
ENSMUST00000105358.8
ENSMUST00000105357.2 ENSMUST00000105354.8 ENSMUST00000105355.8 |
Reep6
|
receptor accessory protein 6 |
chr16_-_38115172 | 10.65 |
ENSMUST00000023504.5
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr3_+_28752050 | 10.58 |
ENSMUST00000029240.14
|
Slc2a2
|
solute carrier family 2 (facilitated glucose transporter), member 2 |
chr3_+_57332735 | 10.32 |
ENSMUST00000029377.8
|
Tm4sf4
|
transmembrane 4 superfamily member 4 |
chr4_-_61437704 | 9.76 |
ENSMUST00000095051.6
ENSMUST00000107483.8 |
Mup16
|
major urinary protein 16 |
chr9_+_46151994 | 9.65 |
ENSMUST00000034585.7
|
Apoa4
|
apolipoprotein A-IV |
chr7_+_26819334 | 9.56 |
ENSMUST00000003100.10
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr10_+_59239466 | 9.33 |
ENSMUST00000009790.14
|
Pla2g12b
|
phospholipase A2, group XIIB |
chr6_+_90310252 | 9.30 |
ENSMUST00000046128.12
ENSMUST00000164761.6 |
Uroc1
|
urocanase domain containing 1 |
chr15_-_96947963 | 9.29 |
ENSMUST00000230907.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr10_-_127843377 | 9.13 |
ENSMUST00000219447.2
ENSMUST00000219780.2 ENSMUST00000219707.2 ENSMUST00000219953.2 ENSMUST00000219183.2 |
Hsd17b6
|
hydroxysteroid (17-beta) dehydrogenase 6 |
chr5_-_145816774 | 9.00 |
ENSMUST00000035918.8
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr17_+_84990541 | 8.92 |
ENSMUST00000045714.15
ENSMUST00000171915.2 |
Abcg8
|
ATP binding cassette subfamily G member 8 |
chr12_+_87193922 | 8.90 |
ENSMUST00000222885.2
|
Gstz1
|
glutathione transferase zeta 1 (maleylacetoacetate isomerase) |
chr4_+_134123631 | 8.85 |
ENSMUST00000105869.9
|
Pafah2
|
platelet-activating factor acetylhydrolase 2 |
chr8_+_105652867 | 8.57 |
ENSMUST00000034355.11
ENSMUST00000109410.4 |
Ces2e
|
carboxylesterase 2E |
chr13_-_64277115 | 8.56 |
ENSMUST00000220792.2
ENSMUST00000222866.2 ENSMUST00000099441.6 ENSMUST00000222168.2 |
Slc35d2
|
solute carrier family 35, member D2 |
chr13_+_4099001 | 8.41 |
ENSMUST00000118717.10
|
Akr1c14
|
aldo-keto reductase family 1, member C14 |
chr4_+_63262775 | 8.28 |
ENSMUST00000030044.3
|
Orm1
|
orosomucoid 1 |
chr3_+_96432479 | 8.27 |
ENSMUST00000049208.11
|
Hjv
|
hemojuvelin BMP co-receptor |
chr7_-_105249308 | 8.23 |
ENSMUST00000210531.2
ENSMUST00000033185.10 |
Hpx
|
hemopexin |
chr5_-_145946408 | 8.20 |
ENSMUST00000138870.2
ENSMUST00000068317.13 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr9_-_46146558 | 8.14 |
ENSMUST00000121916.8
ENSMUST00000034586.9 |
Apoc3
|
apolipoprotein C-III |
chr12_-_57592907 | 8.07 |
ENSMUST00000044380.8
|
Foxa1
|
forkhead box A1 |
chr6_-_3988900 | 8.04 |
ENSMUST00000183682.3
|
Tfpi2
|
tissue factor pathway inhibitor 2 |
chr4_-_60222580 | 8.01 |
ENSMUST00000095058.5
ENSMUST00000163931.8 |
Mup8
|
major urinary protein 8 |
chr3_-_131138541 | 8.01 |
ENSMUST00000090246.5
ENSMUST00000126569.2 |
Sgms2
|
sphingomyelin synthase 2 |
chr8_+_126637165 | 7.93 |
ENSMUST00000034316.6
|
Map3k21
|
mitogen-activated protein kinase kinase kinase 21 |
chr10_+_80165961 | 7.91 |
ENSMUST00000186864.7
ENSMUST00000040081.7 |
Reep6
|
receptor accessory protein 6 |
chr6_-_3988835 | 7.84 |
ENSMUST00000203257.2
|
Tfpi2
|
tissue factor pathway inhibitor 2 |
chr9_+_46180362 | 7.83 |
ENSMUST00000214202.2
ENSMUST00000215458.2 ENSMUST00000215187.2 ENSMUST00000213878.2 ENSMUST00000034584.4 |
Apoa5
|
apolipoprotein A-V |
chrX_+_100427331 | 7.70 |
ENSMUST00000119190.2
|
Gjb1
|
gap junction protein, beta 1 |
chr4_-_61259997 | 7.68 |
ENSMUST00000071005.9
ENSMUST00000075206.12 |
Mup14
|
major urinary protein 14 |
chr9_-_70859418 | 7.63 |
ENSMUST00000216798.2
|
Lipc
|
lipase, hepatic |
chr10_+_127702326 | 7.62 |
ENSMUST00000092058.4
|
Rdh16f2
|
RDH16 family member 2 |
chr4_-_63073028 | 7.61 |
ENSMUST00000142901.2
|
Ambp
|
alpha 1 microglobulin/bikunin precursor |
chr3_+_82915031 | 7.59 |
ENSMUST00000048486.13
ENSMUST00000194175.2 |
Fgg
|
fibrinogen gamma chain |
chr16_+_4825216 | 7.57 |
ENSMUST00000185147.8
|
Smim22
|
small integral membrane protein 22 |
chr10_+_87357816 | 7.46 |
ENSMUST00000218573.2
|
Pah
|
phenylalanine hydroxylase |
chr7_-_30672824 | 7.45 |
ENSMUST00000147431.2
ENSMUST00000098553.11 ENSMUST00000108116.10 |
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr19_+_12610668 | 7.36 |
ENSMUST00000044976.12
|
Glyat
|
glycine-N-acyltransferase |
chr7_-_30672747 | 7.32 |
ENSMUST00000205961.2
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr4_+_115156243 | 7.27 |
ENSMUST00000084343.4
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr16_+_22710027 | 7.15 |
ENSMUST00000231848.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr14_+_75479727 | 7.12 |
ENSMUST00000022576.10
|
Cpb2
|
carboxypeptidase B2 (plasma) |
chr17_+_57369231 | 7.11 |
ENSMUST00000097299.10
ENSMUST00000169543.8 ENSMUST00000163763.2 |
Crb3
|
crumbs family member 3 |
chr1_-_184543367 | 7.09 |
ENSMUST00000048462.13
ENSMUST00000110992.9 |
Mtarc1
|
mitochondrial amidoxime reducing component 1 |
chr10_+_97315465 | 7.08 |
ENSMUST00000105287.11
|
Dcn
|
decorin |
chr3_-_94693780 | 7.08 |
ENSMUST00000107273.9
ENSMUST00000238849.2 |
Cgn
|
cingulin |
chr7_-_30672889 | 7.03 |
ENSMUST00000001279.15
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr19_+_43770619 | 7.02 |
ENSMUST00000026208.6
|
Abcc2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
chr15_+_76579960 | 6.99 |
ENSMUST00000229679.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr12_+_87194476 | 6.96 |
ENSMUST00000063117.10
ENSMUST00000220574.2 |
Gstz1
|
glutathione transferase zeta 1 (maleylacetoacetate isomerase) |
chr1_+_171265103 | 6.93 |
ENSMUST00000043839.5
|
F11r
|
F11 receptor |
chr17_-_35077089 | 6.91 |
ENSMUST00000153400.8
|
Cfb
|
complement factor B |
chr1_-_139487951 | 6.83 |
ENSMUST00000023965.8
|
Cfhr1
|
complement factor H-related 1 |
chr15_+_10224052 | 6.80 |
ENSMUST00000128450.8
ENSMUST00000148257.8 ENSMUST00000128921.8 |
Prlr
|
prolactin receptor |
chr6_-_3968365 | 6.76 |
ENSMUST00000031674.11
|
Tfpi2
|
tissue factor pathway inhibitor 2 |
chr10_+_3490232 | 6.71 |
ENSMUST00000019896.5
|
Iyd
|
iodotyrosine deiodinase |
chr15_+_76579885 | 6.66 |
ENSMUST00000231028.2
|
Gpt
|
glutamic pyruvic transaminase, soluble |
chr16_+_17149235 | 6.64 |
ENSMUST00000023450.15
ENSMUST00000231884.2 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr1_-_140111018 | 6.63 |
ENSMUST00000192880.6
ENSMUST00000111977.8 |
Cfh
|
complement component factor h |
chr1_+_93062962 | 6.62 |
ENSMUST00000027491.7
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr4_-_60538151 | 6.40 |
ENSMUST00000098047.3
|
Mup10
|
major urinary protein 10 |
chr1_+_4878046 | 6.39 |
ENSMUST00000027036.11
ENSMUST00000150971.8 ENSMUST00000119612.9 ENSMUST00000137887.8 ENSMUST00000115529.8 |
Lypla1
|
lysophospholipase 1 |
chr4_+_115458172 | 6.39 |
ENSMUST00000084342.6
|
Cyp4a32
|
cytochrome P450, family 4, subfamily a, polypeptide 32 |
chr1_+_88066086 | 6.38 |
ENSMUST00000014263.6
|
Ugt1a6a
|
UDP glucuronosyltransferase 1 family, polypeptide A6A |
chr4_-_60457902 | 6.37 |
ENSMUST00000084548.11
ENSMUST00000103012.10 ENSMUST00000107499.4 |
Mup1
|
major urinary protein 1 |
chr11_-_89893707 | 6.36 |
ENSMUST00000020864.9
|
Pctp
|
phosphatidylcholine transfer protein |
chr14_+_30608433 | 6.35 |
ENSMUST00000120269.11
ENSMUST00000078490.14 ENSMUST00000006703.15 |
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr4_-_60618357 | 6.30 |
ENSMUST00000084544.5
ENSMUST00000098046.10 |
Mup11
|
major urinary protein 11 |
chr14_-_34077340 | 6.29 |
ENSMUST00000052126.6
|
Fam25c
|
family with sequence similarity 25, member C |
chr4_-_138095277 | 6.29 |
ENSMUST00000030535.4
|
Cda
|
cytidine deaminase |
chr11_-_102298141 | 6.26 |
ENSMUST00000149777.8
ENSMUST00000154001.8 |
Slc25a39
|
solute carrier family 25, member 39 |
chr9_-_9239056 | 6.22 |
ENSMUST00000093893.12
|
Arhgap42
|
Rho GTPase activating protein 42 |
chr7_+_30673212 | 6.18 |
ENSMUST00000129773.2
|
Fam187b
|
family with sequence similarity 187, member B |
chr8_+_105460627 | 6.14 |
ENSMUST00000034346.15
ENSMUST00000164182.3 |
Ces2a
|
carboxylesterase 2A |
chr10_+_128089965 | 6.13 |
ENSMUST00000060782.5
ENSMUST00000218722.2 |
Apon
|
apolipoprotein N |
chr4_-_61592331 | 6.12 |
ENSMUST00000098040.4
|
Mup18
|
major urinary protein 18 |
chr6_+_90527762 | 6.07 |
ENSMUST00000130418.8
ENSMUST00000032175.11 ENSMUST00000203111.2 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr1_-_140111138 | 6.06 |
ENSMUST00000111976.9
ENSMUST00000066859.13 |
Cfh
|
complement component factor h |
chr16_+_4825170 | 6.03 |
ENSMUST00000178155.9
|
Smim22
|
small integral membrane protein 22 |
chr19_+_12577317 | 5.97 |
ENSMUST00000181868.8
ENSMUST00000092931.7 |
Gm4952
|
predicted gene 4952 |
chr4_+_115420817 | 5.97 |
ENSMUST00000141033.8
ENSMUST00000030486.15 |
Cyp4a31
|
cytochrome P450, family 4, subfamily a, polypeptide 31 |
chr17_-_28779678 | 5.94 |
ENSMUST00000114785.3
ENSMUST00000025062.5 |
Clps
|
colipase, pancreatic |
chr19_-_8109346 | 5.92 |
ENSMUST00000065651.5
|
Slc22a28
|
solute carrier family 22, member 28 |
chr11_+_75400889 | 5.90 |
ENSMUST00000042972.7
|
Rilp
|
Rab interacting lysosomal protein |
chr14_+_30608478 | 5.89 |
ENSMUST00000168782.4
|
Itih4
|
inter alpha-trypsin inhibitor, heavy chain 4 |
chr3_-_157630690 | 5.89 |
ENSMUST00000118539.2
|
Cth
|
cystathionase (cystathionine gamma-lyase) |
chr12_-_103739847 | 5.85 |
ENSMUST00000078869.6
|
Serpina1d
|
serine (or cysteine) peptidase inhibitor, clade A, member 1D |
chrX_-_47602395 | 5.84 |
ENSMUST00000114945.9
ENSMUST00000037349.8 |
Aifm1
|
apoptosis-inducing factor, mitochondrion-associated 1 |
chr17_-_84990360 | 5.84 |
ENSMUST00000066175.10
|
Abcg5
|
ATP binding cassette subfamily G member 5 |
chr8_-_84738761 | 5.83 |
ENSMUST00000191523.2
ENSMUST00000190457.2 ENSMUST00000185457.2 |
Misp3
|
MISP family member 3 |
chr9_-_46146928 | 5.82 |
ENSMUST00000118649.8
|
Apoc3
|
apolipoprotein C-III |
chr8_-_3517617 | 5.82 |
ENSMUST00000111081.10
ENSMUST00000004686.13 |
Pex11g
|
peroxisomal biogenesis factor 11 gamma |
chr2_+_105054657 | 5.79 |
ENSMUST00000068813.3
|
Them7
|
thioesterase superfamily member 7 |
chr7_+_43910845 | 5.77 |
ENSMUST00000124863.4
|
Gm15517
|
predicted gene 15517 |
chr14_-_30637344 | 5.74 |
ENSMUST00000226547.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr6_-_42350188 | 5.73 |
ENSMUST00000073387.5
ENSMUST00000204357.2 |
Epha1
|
Eph receptor A1 |
chr16_+_22713593 | 5.73 |
ENSMUST00000232674.2
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr5_-_87716882 | 5.72 |
ENSMUST00000113314.3
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr4_+_115420876 | 5.69 |
ENSMUST00000126645.8
ENSMUST00000030480.4 |
Cyp4a31
|
cytochrome P450, family 4, subfamily a, polypeptide 31 |
chr4_-_60777462 | 5.65 |
ENSMUST00000211875.2
|
Mup22
|
major urinary protein 22 |
chr11_+_75358866 | 5.64 |
ENSMUST00000043598.14
ENSMUST00000108435.2 |
Tlcd2
|
TLC domain containing 2 |
chr1_+_78488499 | 5.57 |
ENSMUST00000012331.7
|
Mogat1
|
monoacylglycerol O-acyltransferase 1 |
chr15_+_82338247 | 5.57 |
ENSMUST00000230000.2
|
Cyp2d9
|
cytochrome P450, family 2, subfamily d, polypeptide 9 |
chr5_+_146016064 | 5.56 |
ENSMUST00000035571.10
|
Cyp3a59
|
cytochrome P450, family 3, subfamily a, polypeptide 59 |
chr17_+_25097199 | 5.50 |
ENSMUST00000050714.8
|
Igfals
|
insulin-like growth factor binding protein, acid labile subunit |
chr14_-_63482668 | 5.43 |
ENSMUST00000118022.8
|
Gata4
|
GATA binding protein 4 |
chr9_+_99494550 | 5.42 |
ENSMUST00000042553.8
|
A4gnt
|
alpha-1,4-N-acetylglucosaminyltransferase |
chr6_-_142418801 | 5.38 |
ENSMUST00000032371.8
|
Gys2
|
glycogen synthase 2 |
chr19_+_4036562 | 5.38 |
ENSMUST00000236224.2
ENSMUST00000236510.2 ENSMUST00000237910.2 ENSMUST00000235612.2 ENSMUST00000054030.8 |
Acy3
|
aspartoacylase (aminoacylase) 3 |
chr9_-_22043083 | 5.37 |
ENSMUST00000069330.14
ENSMUST00000217643.2 |
Acp5
|
acid phosphatase 5, tartrate resistant |
chr19_-_44017637 | 5.35 |
ENSMUST00000026211.10
ENSMUST00000211830.2 |
Cyp2c23
|
cytochrome P450, family 2, subfamily c, polypeptide 23 |
chr2_+_172994841 | 5.34 |
ENSMUST00000029017.6
|
Pck1
|
phosphoenolpyruvate carboxykinase 1, cytosolic |
chr17_-_33136277 | 5.33 |
ENSMUST00000234538.2
ENSMUST00000235058.2 ENSMUST00000234759.2 ENSMUST00000179434.8 ENSMUST00000234797.2 |
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr11_+_69945157 | 5.30 |
ENSMUST00000108585.9
ENSMUST00000018699.13 |
Asgr1
|
asialoglycoprotein receptor 1 |
chr1_-_135186176 | 5.29 |
ENSMUST00000185752.2
ENSMUST00000003135.14 |
Elf3
|
E74-like factor 3 |
chr2_+_122065230 | 5.27 |
ENSMUST00000110551.4
|
Sord
|
sorbitol dehydrogenase |
chr2_-_25391729 | 5.25 |
ENSMUST00000015227.4
|
C8g
|
complement component 8, gamma polypeptide |
chr18_-_56695259 | 5.25 |
ENSMUST00000171844.3
|
Aldh7a1
|
aldehyde dehydrogenase family 7, member A1 |
chr2_-_27137272 | 5.24 |
ENSMUST00000102886.10
ENSMUST00000129975.2 |
Sardh
|
sarcosine dehydrogenase |
chr1_+_87998487 | 5.23 |
ENSMUST00000073772.5
|
Ugt1a9
|
UDP glucuronosyltransferase 1 family, polypeptide A9 |
chr1_+_88093726 | 5.23 |
ENSMUST00000097659.5
|
Ugt1a5
|
UDP glucuronosyltransferase 1 family, polypeptide A5 |
chr14_-_66246652 | 5.22 |
ENSMUST00000059970.9
|
Gulo
|
gulonolactone (L-) oxidase |
chr1_+_139429430 | 5.22 |
ENSMUST00000027615.7
|
F13b
|
coagulation factor XIII, beta subunit |
chr14_-_30645503 | 5.20 |
ENSMUST00000227995.2
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr5_-_87288177 | 5.18 |
ENSMUST00000067790.7
|
Ugt2b5
|
UDP glucuronosyltransferase 2 family, polypeptide B5 |
chr7_-_140856642 | 5.13 |
ENSMUST00000080654.7
ENSMUST00000167263.9 |
Cdhr5
|
cadherin-related family member 5 |
chr3_+_96736774 | 5.12 |
ENSMUST00000138014.8
|
Pdzk1
|
PDZ domain containing 1 |
chr15_-_34495329 | 5.11 |
ENSMUST00000022946.6
|
Rida
|
reactive intermediate imine deaminase A homolog |
chr2_+_4923815 | 5.08 |
ENSMUST00000027975.8
|
Phyh
|
phytanoyl-CoA hydroxylase |
chr14_-_63482720 | 5.08 |
ENSMUST00000067417.10
|
Gata4
|
GATA binding protein 4 |
chr13_-_42001102 | 5.07 |
ENSMUST00000121404.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr11_-_116089595 | 5.03 |
ENSMUST00000072948.11
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr13_-_42001075 | 5.02 |
ENSMUST00000179758.8
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr4_-_15945359 | 5.02 |
ENSMUST00000029877.9
|
Decr1
|
2,4-dienoyl CoA reductase 1, mitochondrial |
chr2_+_58645189 | 5.01 |
ENSMUST00000102755.4
ENSMUST00000230627.2 ENSMUST00000229923.2 |
Upp2
|
uridine phosphorylase 2 |
chr17_-_31363245 | 4.99 |
ENSMUST00000024826.8
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr3_-_81883509 | 4.98 |
ENSMUST00000029645.14
ENSMUST00000193879.2 |
Tdo2
|
tryptophan 2,3-dioxygenase |
chr13_-_42000958 | 4.97 |
ENSMUST00000072012.10
|
Adtrp
|
androgen dependent TFPI regulating protein |
chr10_-_127206300 | 4.97 |
ENSMUST00000026472.10
|
Inhbc
|
inhibin beta-C |
chr19_-_7780025 | 4.96 |
ENSMUST00000065634.8
|
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr5_+_137568086 | 4.95 |
ENSMUST00000198866.5
|
Tfr2
|
transferrin receptor 2 |
chr6_+_121815473 | 4.95 |
ENSMUST00000032228.9
|
Mug1
|
murinoglobulin 1 |
chr15_+_75088220 | 4.94 |
ENSMUST00000185307.7
ENSMUST00000229521.2 |
Ly6g2
|
lymphocyte antigen 6 complex, locus G2 |
chr7_+_28524627 | 4.94 |
ENSMUST00000066264.13
|
Ech1
|
enoyl coenzyme A hydratase 1, peroxisomal |
chr13_-_63006176 | 4.93 |
ENSMUST00000021907.9
|
Fbp2
|
fructose bisphosphatase 2 |
chrX_+_138464065 | 4.93 |
ENSMUST00000113027.8
|
Rnf128
|
ring finger protein 128 |
chr8_+_105573693 | 4.93 |
ENSMUST00000055052.6
|
Ces2c
|
carboxylesterase 2C |
chr4_-_115504907 | 4.92 |
ENSMUST00000102707.10
|
Cyp4b1
|
cytochrome P450, family 4, subfamily b, polypeptide 1 |
chr8_-_106863521 | 4.92 |
ENSMUST00000115979.9
|
Esrp2
|
epithelial splicing regulatory protein 2 |
chr13_-_55574596 | 4.89 |
ENSMUST00000021948.15
|
F12
|
coagulation factor XII (Hageman factor) |
chr19_-_10581622 | 4.88 |
ENSMUST00000037678.7
|
Tkfc
|
triokinase, FMN cyclase |
chr6_-_23132977 | 4.86 |
ENSMUST00000031707.14
|
Aass
|
aminoadipate-semialdehyde synthase |
chr11_+_108271990 | 4.86 |
ENSMUST00000146050.2
ENSMUST00000152958.8 |
Apoh
|
apolipoprotein H |
chr4_-_61259801 | 4.86 |
ENSMUST00000125461.8
|
Mup14
|
major urinary protein 14 |
chr16_+_22877000 | 4.86 |
ENSMUST00000039492.14
ENSMUST00000023589.15 ENSMUST00000089902.8 |
Kng1
|
kininogen 1 |
chr6_+_42222841 | 4.84 |
ENSMUST00000031897.8
|
Gstk1
|
glutathione S-transferase kappa 1 |
chr9_-_22041894 | 4.82 |
ENSMUST00000115315.3
|
Acp5
|
acid phosphatase 5, tartrate resistant |
chr7_-_19556612 | 4.79 |
ENSMUST00000120537.8
|
Bcl3
|
B cell leukemia/lymphoma 3 |
chr12_-_81014849 | 4.77 |
ENSMUST00000095572.5
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr3_+_94600863 | 4.75 |
ENSMUST00000090848.10
ENSMUST00000173981.8 ENSMUST00000173849.8 ENSMUST00000174223.2 |
Selenbp2
|
selenium binding protein 2 |
chr9_-_15212849 | 4.75 |
ENSMUST00000034414.10
|
4931406C07Rik
|
RIKEN cDNA 4931406C07 gene |
chr4_-_129121676 | 4.73 |
ENSMUST00000106051.8
|
C77080
|
expressed sequence C77080 |
chr19_+_38384428 | 4.73 |
ENSMUST00000054098.4
|
Slc35g1
|
solute carrier family 35, member G1 |
chr3_+_94840352 | 4.70 |
ENSMUST00000090839.12
|
Selenbp1
|
selenium binding protein 1 |
chr17_-_59320257 | 4.70 |
ENSMUST00000174122.2
ENSMUST00000025065.12 |
Nudt12
|
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
chr15_+_10314173 | 4.70 |
ENSMUST00000127467.3
|
Prlr
|
prolactin receptor |
chr2_+_43445333 | 4.68 |
ENSMUST00000028223.9
ENSMUST00000112826.8 |
Kynu
|
kynureninase |
chr3_-_137837117 | 4.67 |
ENSMUST00000029805.13
|
Mttp
|
microsomal triglyceride transfer protein |
chr14_+_14210394 | 4.64 |
ENSMUST00000164598.8
|
Acox2
|
acyl-Coenzyme A oxidase 2, branched chain |
chr4_+_104623505 | 4.61 |
ENSMUST00000031663.10
ENSMUST00000065072.7 |
C8b
|
complement component 8, beta polypeptide |
chr4_-_60070411 | 4.61 |
ENSMUST00000079697.10
ENSMUST00000125282.2 ENSMUST00000166098.8 |
Mup7
|
major urinary protein 7 |
chr4_+_63280675 | 4.60 |
ENSMUST00000075341.4
|
Orm2
|
orosomucoid 2 |
chr1_-_130589321 | 4.60 |
ENSMUST00000137276.3
|
C4bp
|
complement component 4 binding protein |
chr10_+_87695352 | 4.60 |
ENSMUST00000121952.8
ENSMUST00000126490.8 |
Igf1
|
insulin-like growth factor 1 |
chr4_-_60139857 | 4.58 |
ENSMUST00000107490.5
ENSMUST00000074700.9 |
Mup2
|
major urinary protein 2 |
chr6_+_121277693 | 4.57 |
ENSMUST00000142419.2
|
Slc6a13
|
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 |
chr7_-_100661181 | 4.57 |
ENSMUST00000178340.3
ENSMUST00000037540.5 |
P2ry2
|
purinergic receptor P2Y, G-protein coupled 2 |
chr4_-_62005498 | 4.56 |
ENSMUST00000107488.4
ENSMUST00000107472.8 ENSMUST00000084531.11 |
Mup3
|
major urinary protein 3 |
chr17_-_31852128 | 4.56 |
ENSMUST00000236909.2
|
Cbs
|
cystathionine beta-synthase |
chr5_+_52521133 | 4.52 |
ENSMUST00000101208.6
|
Sod3
|
superoxide dismutase 3, extracellular |
chr15_-_96929086 | 4.51 |
ENSMUST00000230086.2
|
Slc38a4
|
solute carrier family 38, member 4 |
chr15_-_31453708 | 4.50 |
ENSMUST00000110408.3
|
Ropn1l
|
ropporin 1-like |
chrX_-_16683578 | 4.49 |
ENSMUST00000040820.13
|
Maob
|
monoamine oxidase B |
chr12_-_81014755 | 4.46 |
ENSMUST00000218342.2
|
Slc10a1
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
chr3_+_96736600 | 4.45 |
ENSMUST00000135031.8
|
Pdzk1
|
PDZ domain containing 1 |
chr3_-_107925159 | 4.40 |
ENSMUST00000004140.11
|
Gstm1
|
glutathione S-transferase, mu 1 |
chr4_-_60697274 | 4.40 |
ENSMUST00000117932.2
|
Mup12
|
major urinary protein 12 |
chr10_+_23770586 | 4.39 |
ENSMUST00000041416.8
|
Vnn1
|
vanin 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 30.1 | GO:0009095 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
7.3 | 21.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
6.2 | 24.6 | GO:0046226 | coumarin catabolic process(GO:0046226) |
5.9 | 23.5 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
4.7 | 14.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
4.4 | 13.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
3.5 | 10.5 | GO:0060540 | lung lobe formation(GO:0060464) diaphragm morphogenesis(GO:0060540) |
3.5 | 14.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
3.4 | 16.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
3.3 | 6.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
3.3 | 23.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
3.2 | 9.6 | GO:0018931 | naphthalene metabolic process(GO:0018931) naphthalene-containing compound metabolic process(GO:0090420) |
3.0 | 9.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
3.0 | 17.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.9 | 8.8 | GO:0006553 | lysine metabolic process(GO:0006553) |
2.9 | 14.3 | GO:0034371 | chylomicron remodeling(GO:0034371) |
2.9 | 14.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
2.8 | 13.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
2.7 | 13.6 | GO:0006548 | histidine catabolic process(GO:0006548) |
2.7 | 8.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
2.6 | 10.5 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
2.4 | 12.1 | GO:1904970 | brush border assembly(GO:1904970) |
2.4 | 23.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
2.4 | 7.1 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
2.3 | 9.3 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
2.3 | 9.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
2.3 | 18.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
2.3 | 6.8 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
2.2 | 6.6 | GO:0046724 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) L-alanine catabolic process(GO:0042853) oxalic acid secretion(GO:0046724) |
2.1 | 18.9 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
2.0 | 12.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.0 | 6.1 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
2.0 | 13.8 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
2.0 | 7.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.0 | 5.9 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
1.9 | 5.8 | GO:0051977 | lysophospholipid transport(GO:0051977) |
1.9 | 11.5 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.9 | 5.7 | GO:1903412 | response to bile acid(GO:1903412) cellular response to bile acid(GO:1903413) |
1.9 | 9.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
1.9 | 5.6 | GO:1903920 | positive regulation of actin filament severing(GO:1903920) |
1.9 | 7.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.8 | 27.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
1.7 | 5.2 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.7 | 5.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
1.7 | 6.9 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) response to selenium ion(GO:0010269) |
1.7 | 5.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.7 | 11.7 | GO:0015886 | heme transport(GO:0015886) |
1.7 | 6.7 | GO:0061296 | regulation of pronephros size(GO:0035565) mesonephros morphogenesis(GO:0061206) mesonephric nephron development(GO:0061215) mesonephric nephron morphogenesis(GO:0061228) mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis(GO:0061235) regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061295) negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:0061296) mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis(GO:1901146) |
1.6 | 18.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.6 | 24.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.6 | 8.1 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
1.6 | 1.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.6 | 4.8 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.5 | 4.6 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
1.5 | 15.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.5 | 9.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.5 | 7.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
1.5 | 20.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.4 | 15.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.4 | 2.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.4 | 8.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.4 | 4.1 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
1.4 | 4.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
1.4 | 1.4 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
1.3 | 4.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.3 | 6.5 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
1.3 | 9.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
1.3 | 7.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.2 | 18.7 | GO:0015747 | urate transport(GO:0015747) |
1.2 | 4.9 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
1.2 | 7.3 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
1.2 | 3.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.2 | 6.0 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.2 | 7.2 | GO:0032902 | nerve growth factor production(GO:0032902) |
1.2 | 3.5 | GO:0042197 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
1.2 | 12.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
1.1 | 12.4 | GO:0015879 | carnitine transport(GO:0015879) |
1.1 | 11.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.1 | 3.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.1 | 4.4 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
1.1 | 3.2 | GO:1904344 | regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
1.1 | 2.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.1 | 4.3 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
1.1 | 6.4 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
1.0 | 3.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
1.0 | 5.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
1.0 | 13.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.0 | 3.1 | GO:0006562 | proline catabolic process(GO:0006562) |
1.0 | 4.1 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
1.0 | 8.1 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
1.0 | 3.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.0 | 1.0 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
1.0 | 7.9 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.0 | 3.9 | GO:0015744 | succinate transport(GO:0015744) |
1.0 | 5.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
1.0 | 3.8 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.9 | 4.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.9 | 8.5 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.9 | 2.8 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.9 | 1.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 2.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.9 | 1.8 | GO:0060003 | copper ion export(GO:0060003) |
0.9 | 1.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.9 | 2.7 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.9 | 3.5 | GO:1902896 | terminal web assembly(GO:1902896) |
0.9 | 5.3 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.9 | 4.3 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.9 | 6.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.9 | 4.3 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.9 | 7.8 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.9 | 4.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.9 | 6.0 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.9 | 3.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.8 | 3.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.8 | 2.5 | GO:0002149 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
0.8 | 3.3 | GO:1901535 | C-5 methylation of cytosine(GO:0090116) regulation of DNA demethylation(GO:1901535) |
0.8 | 9.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.8 | 4.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.8 | 5.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.8 | 3.3 | GO:1901373 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.8 | 4.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.8 | 3.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.8 | 1.6 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
0.8 | 0.8 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.8 | 8.8 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.8 | 0.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.8 | 1.6 | GO:2000417 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) negative regulation of eosinophil migration(GO:2000417) |
0.8 | 5.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.8 | 5.5 | GO:0015862 | uridine transport(GO:0015862) |
0.8 | 4.7 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.8 | 1.5 | GO:0034310 | sesquiterpenoid metabolic process(GO:0006714) primary alcohol catabolic process(GO:0034310) |
0.7 | 2.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.7 | 2.2 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.7 | 3.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.7 | 2.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.7 | 3.7 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.7 | 3.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.7 | 2.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.7 | 41.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.7 | 4.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.7 | 1.4 | GO:0070178 | D-serine metabolic process(GO:0070178) |
0.7 | 2.9 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.7 | 2.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.7 | 2.1 | GO:0007509 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) mesoderm migration involved in gastrulation(GO:0007509) |
0.7 | 9.2 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.7 | 2.1 | GO:0038190 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
0.7 | 2.8 | GO:0044108 | cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.7 | 13.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 6.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.7 | 4.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.7 | 2.0 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 19.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.7 | 2.7 | GO:0090282 | positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.7 | 4.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 2.0 | GO:1990697 | GPI anchor release(GO:0006507) protein depalmitoleylation(GO:1990697) |
0.7 | 2.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 2.6 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.7 | 2.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 3.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.6 | 1.3 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
0.6 | 3.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 5.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.6 | 3.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.6 | 1.3 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.6 | 2.6 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 3.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 1.3 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.6 | 1.9 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
0.6 | 1.9 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.6 | 2.5 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.6 | 3.1 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.6 | 3.1 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.6 | 3.6 | GO:1990839 | response to endothelin(GO:1990839) |
0.6 | 5.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 1.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.6 | 7.0 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.6 | 1.2 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.6 | 3.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.6 | 1.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.6 | 7.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.6 | 5.6 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 1.7 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.6 | 3.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.6 | 2.2 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.6 | 3.9 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.6 | 8.8 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 2.2 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.5 | 2.2 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.5 | 3.2 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.5 | 3.2 | GO:0032439 | endosome localization(GO:0032439) |
0.5 | 38.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.5 | 13.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.5 | 4.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 3.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.5 | 12.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.5 | 5.2 | GO:0060974 | cell migration involved in heart formation(GO:0060974) |
0.5 | 6.7 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.5 | 3.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.5 | 2.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 2.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.5 | 2.5 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 1.0 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.5 | 1.5 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.5 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.5 | 2.0 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.5 | 2.5 | GO:0070295 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.5 | 15.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.5 | 5.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.5 | 5.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.5 | 5.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 8.7 | GO:0050892 | intestinal absorption(GO:0050892) |
0.5 | 1.4 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.5 | 1.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 1.0 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.5 | 1.4 | GO:1990168 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.5 | 4.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.5 | 3.3 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
0.5 | 1.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.5 | 7.9 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.5 | 1.4 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.5 | 0.9 | GO:1902336 | positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
0.5 | 13.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 2.3 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.5 | 12.7 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.5 | 5.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.4 | 1.8 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 1.8 | GO:0015811 | L-cystine transport(GO:0015811) |
0.4 | 2.7 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.4 | 2.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.4 | 2.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 3.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.4 | 1.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.4 | 1.7 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.4 | 3.0 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.4 | 1.3 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.4 | 1.7 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 4.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 2.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.4 | 2.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.4 | 0.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.4 | 0.8 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.4 | 2.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.4 | 2.9 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.4 | 1.2 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.4 | 4.0 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.4 | 0.8 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.4 | 0.4 | GO:0035938 | estradiol secretion(GO:0035938) regulation of estradiol secretion(GO:2000864) |
0.4 | 1.6 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 0.4 | GO:0042335 | cuticle development(GO:0042335) |
0.4 | 1.2 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
0.4 | 1.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 1.5 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.4 | 1.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.4 | 1.9 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 1.5 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.4 | 2.2 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.4 | 1.8 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.4 | 1.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.4 | 1.8 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 1.1 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.4 | 1.1 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
0.4 | 2.1 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.3 | 2.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 1.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 1.4 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.3 | 1.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 1.0 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 1.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 0.7 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 1.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 1.4 | GO:1902477 | defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.3 | 1.4 | GO:0010286 | heat acclimation(GO:0010286) |
0.3 | 1.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.3 | 2.0 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.3 | 1.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.3 | 4.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 11.0 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.3 | 0.7 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.3 | 1.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 2.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.0 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.3 | 2.6 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.3 | 2.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.3 | 2.6 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.3 | 2.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.3 | 1.0 | GO:1904766 | negative regulation of macroautophagy by TORC1 signaling(GO:1904766) |
0.3 | 10.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.3 | 3.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 1.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 1.0 | GO:0061090 | positive regulation of sequestering of zinc ion(GO:0061090) |
0.3 | 1.0 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.3 | 0.6 | GO:0046689 | response to mercury ion(GO:0046689) |
0.3 | 2.5 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.3 | 3.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 4.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.3 | 2.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 0.9 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 1.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 1.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 19.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 1.8 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 5.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 3.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 14.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 3.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 2.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 2.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.3 | 0.9 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.3 | 2.3 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 0.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 1.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 2.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.3 | 1.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.9 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.3 | 1.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 2.0 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.3 | 2.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 0.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.3 | 6.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 0.8 | GO:0015898 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
0.3 | 8.4 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 1.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.3 | 1.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 1.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.3 | 2.2 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 1.6 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 1.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 0.8 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 5.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.3 | 1.6 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 1.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.3 | 1.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 1.3 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 1.1 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 0.8 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.3 | 3.4 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 0.5 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.3 | 1.8 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 1.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 0.8 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
0.3 | 1.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.3 | 0.5 | GO:0038001 | paracrine signaling(GO:0038001) |
0.3 | 1.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.3 | 4.6 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.3 | 1.8 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.3 | 0.8 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.3 | 0.8 | GO:1904582 | positive regulation of intracellular mRNA localization(GO:1904582) |
0.3 | 1.0 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.3 | 0.3 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.3 | 2.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 1.0 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 1.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 4.5 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 2.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.2 | 2.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 2.0 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.2 | 3.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.2 | 2.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 3.4 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.2 | 5.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.2 | 1.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 0.5 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.2 | 4.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 4.8 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.2 | 4.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 4.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.2 | 3.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.7 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.2 | 0.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 1.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 0.7 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 9.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.2 | 16.5 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 2.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.7 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 3.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 4.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.4 | GO:0045818 | negative regulation of glycogen catabolic process(GO:0045818) |
0.2 | 1.5 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 8.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.9 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.2 | 1.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 2.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 0.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 2.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 1.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 2.1 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.2 | 0.8 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.2 | 1.0 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 1.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 2.1 | GO:0044264 | cellular polysaccharide metabolic process(GO:0044264) |
0.2 | 1.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 1.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 0.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.2 | 1.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 1.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 0.4 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.2 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.2 | 0.8 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 1.0 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
0.2 | 1.6 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.2 | 1.0 | GO:0060745 | prostate epithelial cord elongation(GO:0060523) mammary gland branching involved in pregnancy(GO:0060745) |
0.2 | 0.6 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.2 | 1.8 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 4.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 3.4 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.2 | 1.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.2 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 2.0 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.2 | 0.6 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 4.9 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.6 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 3.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 1.0 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.2 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 2.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 0.5 | GO:1900062 | regulation of replicative cell aging(GO:1900062) |
0.2 | 8.1 | GO:0006826 | iron ion transport(GO:0006826) |
0.2 | 9.0 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 2.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.5 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.2 | 0.4 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.2 | 6.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.2 | 1.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.7 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 2.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.2 | 0.5 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.2 | 1.4 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.2 | 2.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 1.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 10.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.2 | 1.7 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 0.3 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
0.2 | 0.8 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 1.8 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 0.8 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.7 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 2.3 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 2.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.2 | 2.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 2.9 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.2 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 0.3 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.2 | 4.8 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.2 | 0.8 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.2 | 4.1 | GO:0042311 | vasodilation(GO:0042311) |
0.2 | 1.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 10.2 | GO:0007586 | digestion(GO:0007586) |
0.2 | 8.3 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 0.8 | GO:0043056 | forward locomotion(GO:0043056) |
0.2 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.2 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.2 | 3.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.1 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.1 | 0.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 2.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 7.7 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.7 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.1 | 1.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 2.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.3 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 2.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.6 | GO:0071336 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.1 | 2.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 3.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 7.6 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 1.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.9 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 1.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.5 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.1 | 0.9 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 4.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 1.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.6 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 2.7 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.8 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 1.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.3 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 24.7 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 1.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 1.6 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 1.6 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.7 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 1.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 1.0 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.5 | GO:0007431 | salivary gland development(GO:0007431) |
0.1 | 1.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.5 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.1 | 0.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 2.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 1.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 3.1 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 1.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 3.1 | GO:0060350 | endochondral bone morphogenesis(GO:0060350) |
0.1 | 1.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 2.7 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 1.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 4.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 5.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.9 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 1.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.9 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 7.2 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.1 | 1.1 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.9 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 1.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 1.0 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 4.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.1 | 0.5 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 4.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.6 | GO:0072077 | renal vesicle morphogenesis(GO:0072077) metanephric renal vesicle morphogenesis(GO:0072283) |
0.1 | 1.2 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.8 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 71.4 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.9 | GO:0061709 | reticulophagy(GO:0061709) |
0.1 | 1.3 | GO:0033561 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.1 | 0.3 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 1.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 0.7 | GO:0032049 | cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.8 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.8 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 1.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.1 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 2.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 2.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:0060931 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.1 | 1.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.8 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 2.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 1.7 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 1.0 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 1.0 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 1.0 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 1.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 2.4 | GO:0032528 | microvillus organization(GO:0032528) |
0.1 | 0.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 1.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 3.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 1.3 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.6 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 1.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 1.3 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.1 | 0.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.6 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.8 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.5 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 1.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 1.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.1 | 1.3 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 1.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.9 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 5.2 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 0.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 1.8 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.9 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 5.0 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.1 | 0.8 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.1 | 0.1 | GO:0051325 | interphase(GO:0051325) mitotic interphase(GO:0051329) regulation of mitotic cell cycle DNA replication(GO:1903463) |
0.1 | 0.8 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 1.5 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.8 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.5 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 1.1 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.1 | 1.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0022601 | menstrual cycle phase(GO:0022601) |
0.1 | 0.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 1.7 | GO:0032835 | glomerulus development(GO:0032835) |
0.1 | 1.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.2 | GO:0052695 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.1 | 0.2 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
0.1 | 1.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 1.2 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 1.0 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.2 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.1 | 0.6 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 2.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 2.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.1 | GO:1902031 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.4 | GO:0055062 | cellular phosphate ion homeostasis(GO:0030643) phosphate ion homeostasis(GO:0055062) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.1 | 0.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.2 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.5 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 12.4 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.3 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 1.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.0 | 0.1 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.0 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.0 | 1.6 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.6 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.0 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 2.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.0 | 1.1 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 1.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0033684 | positive regulation of gonadotropin secretion(GO:0032278) regulation of luteinizing hormone secretion(GO:0033684) positive regulation of luteinizing hormone secretion(GO:0033686) |
0.0 | 0.2 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.0 | 1.3 | GO:0055088 | lipid homeostasis(GO:0055088) |
0.0 | 35.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.0 | 1.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.6 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.8 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0090500 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.0 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:1901213 | positive regulation of skeletal muscle tissue growth(GO:0048633) regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901213) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.0 | 0.4 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 3.5 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.3 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.5 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.5 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.5 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.0 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.5 | GO:0007588 | excretion(GO:0007588) |
0.0 | 0.1 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.0 | 0.8 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.3 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.5 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.0 | 0.2 | GO:0006499 | N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) |
0.0 | 0.3 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.0 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.2 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.0 | 0.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 0.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.4 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.1 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.0 | 0.0 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 0.2 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.9 | GO:0044317 | rod spherule(GO:0044317) |
3.9 | 11.6 | GO:0034359 | mature chylomicron(GO:0034359) |
3.7 | 74.8 | GO:0042627 | chylomicron(GO:0042627) |
2.1 | 2.1 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
1.9 | 19.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.5 | 13.5 | GO:0005579 | membrane attack complex(GO:0005579) |
1.5 | 13.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.4 | 11.3 | GO:0097413 | Lewy body(GO:0097413) |
1.4 | 18.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.2 | 1.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.2 | 14.5 | GO:0045275 | respiratory chain complex III(GO:0045275) |
1.2 | 3.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.1 | 4.5 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
1.0 | 15.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
1.0 | 4.1 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.9 | 4.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.8 | 4.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.8 | 22.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 14.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 5.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.7 | 2.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.7 | 3.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.7 | 2.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.6 | 3.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.6 | 4.4 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.6 | 5.7 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.6 | 5.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 1.9 | GO:0018444 | translation release factor complex(GO:0018444) |
0.6 | 3.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.6 | 15.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 3.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.5 | 2.1 | GO:0005757 | mitochondrial permeability transition pore complex(GO:0005757) |
0.5 | 3.6 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.5 | 7.7 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.5 | 1.5 | GO:0061474 | phagolysosome membrane(GO:0061474) |
0.5 | 1.9 | GO:0044393 | microspike(GO:0044393) |
0.5 | 4.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 3.4 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 1.9 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.5 | 38.3 | GO:0070469 | respiratory chain(GO:0070469) |
0.5 | 6.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 1.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.4 | 1.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.4 | 12.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 1.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 3.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.4 | 11.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.4 | 4.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 10.4 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 1.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.4 | 4.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 1.5 | GO:0070722 | Tle3-Aes complex(GO:0070722) |
0.4 | 1.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 5.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 1.0 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.3 | 1.6 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 4.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 2.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 3.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 1.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 0.3 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
0.3 | 34.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.3 | 35.1 | GO:0005903 | brush border(GO:0005903) |
0.3 | 2.3 | GO:0031673 | H zone(GO:0031673) |
0.3 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 3.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 66.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 1.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 2.1 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 15.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.3 | 1.0 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.3 | 1.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 15.9 | GO:0044438 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.3 | 13.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 1.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 2.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 2.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.7 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 1.2 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 2.8 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 2.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 8.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 18.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 4.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 4.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 3.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 3.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 1.6 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 74.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.2 | 0.8 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.2 | 2.2 | GO:0002177 | manchette(GO:0002177) |
0.2 | 2.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 3.5 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 2.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 1.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 23.3 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 2.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.9 | GO:0017177 | glucosidase II complex(GO:0017177) |
0.2 | 1.1 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 2.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 5.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.5 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 1.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 0.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 2.0 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 3.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 15.6 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 52.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 1.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
0.2 | 20.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 2.7 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.0 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 7.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 3.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 6.7 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.7 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 3.2 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 1.6 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 1.4 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 2.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.6 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 2.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 3.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 1.9 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 2.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.3 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 1.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 20.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 1.9 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 1.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.6 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 6.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 36.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.3 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 1.9 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 6.4 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 12.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 200.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.3 | GO:0098560 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 1.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 1.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 64.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.2 | GO:0070992 | translation initiation complex(GO:0070992) |
0.1 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 2.0 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.3 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0098833 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.0 | 0.7 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 5.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 27.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.3 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.5 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 7.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.6 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 0.0 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.0 | 0.2 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.0 | 0.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.0 | 0.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.2 | 24.6 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
6.1 | 24.3 | GO:0019862 | IgA binding(GO:0019862) |
5.3 | 15.9 | GO:0016034 | maleylacetoacetate isomerase activity(GO:0016034) |
5.2 | 36.7 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
5.1 | 30.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
5.0 | 30.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
4.4 | 17.7 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
3.7 | 11.1 | GO:0045030 | UTP-activated nucleotide receptor activity(GO:0045030) |
3.3 | 13.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
3.3 | 3.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
3.3 | 13.0 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
3.2 | 26.0 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
2.9 | 14.3 | GO:0035478 | chylomicron binding(GO:0035478) |
2.9 | 11.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
2.8 | 13.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.7 | 13.6 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
2.7 | 2.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
2.7 | 5.3 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
2.6 | 15.6 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
2.5 | 10.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
2.3 | 14.0 | GO:0015232 | heme transporter activity(GO:0015232) |
2.3 | 11.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.3 | 13.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
2.2 | 6.5 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
2.1 | 6.4 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
2.1 | 6.4 | GO:0005009 | insulin-activated receptor activity(GO:0005009) |
2.0 | 6.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
2.0 | 7.9 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
2.0 | 9.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.9 | 7.5 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.8 | 5.5 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
1.8 | 12.7 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.8 | 5.4 | GO:0004373 | glycogen (starch) synthase activity(GO:0004373) |
1.8 | 5.3 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
1.7 | 5.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
1.7 | 10.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.7 | 13.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.6 | 4.9 | GO:0004371 | glycerone kinase activity(GO:0004371) FAD-AMP lyase (cyclizing) activity(GO:0034012) triokinase activity(GO:0050354) |
1.6 | 8.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
1.6 | 8.0 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
1.5 | 12.4 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.5 | 4.6 | GO:0070026 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
1.5 | 4.5 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
1.5 | 7.5 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
1.4 | 11.5 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.4 | 7.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.4 | 8.4 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.4 | 8.4 | GO:0004144 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
1.4 | 4.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.4 | 4.1 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) |
1.3 | 8.1 | GO:0004359 | glutaminase activity(GO:0004359) |
1.3 | 8.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
1.3 | 3.9 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
1.3 | 9.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.3 | 5.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.3 | 3.9 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
1.3 | 3.9 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
1.3 | 5.2 | GO:0042806 | fucose binding(GO:0042806) |
1.3 | 5.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
1.3 | 10.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.3 | 6.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
1.2 | 5.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
1.2 | 21.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.2 | 14.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.2 | 4.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.2 | 4.8 | GO:0051435 | BH4 domain binding(GO:0051435) |
1.2 | 10.7 | GO:0035473 | lipase binding(GO:0035473) |
1.2 | 40.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.2 | 3.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
1.2 | 3.5 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
1.2 | 8.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.1 | 26.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.1 | 3.4 | GO:0070404 | NADH binding(GO:0070404) |
1.1 | 3.3 | GO:0008431 | vitamin E binding(GO:0008431) |
1.1 | 6.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
1.1 | 3.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.1 | 3.2 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
1.1 | 7.5 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.1 | 4.3 | GO:0047726 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.0 | 3.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
1.0 | 5.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.0 | 6.0 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.0 | 3.9 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.9 | 8.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.9 | 16.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.9 | 6.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.9 | 2.7 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.9 | 8.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 2.6 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.8 | 3.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.8 | 6.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.8 | 3.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.8 | 13.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.8 | 3.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.8 | 3.3 | GO:0033814 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
0.8 | 2.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.8 | 32.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.8 | 3.9 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
0.8 | 6.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 4.7 | GO:0034618 | arginine binding(GO:0034618) |
0.8 | 3.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.8 | 2.3 | GO:0042602 | riboflavin reductase (NADPH) activity(GO:0042602) |
0.8 | 8.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 22.0 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.8 | 4.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 2.3 | GO:0015152 | glucose-6-phosphate transmembrane transporter activity(GO:0015152) |
0.7 | 2.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.7 | 2.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.7 | 4.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.7 | 2.9 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.7 | 3.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.7 | 5.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 10.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 5.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.7 | 3.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.7 | 3.4 | GO:0047804 | cysteine-S-conjugate beta-lyase activity(GO:0047804) |
0.7 | 2.7 | GO:0047016 | cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity(GO:0047016) |
0.7 | 3.3 | GO:0070287 | ferritin receptor activity(GO:0070287) |
0.7 | 8.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 2.0 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.7 | 2.0 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.7 | 7.9 | GO:0031433 | telethonin binding(GO:0031433) |
0.7 | 2.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.7 | 3.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 1.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.6 | 4.4 | GO:0016151 | nickel cation binding(GO:0016151) |
0.6 | 3.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.6 | 1.9 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 11.1 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 4.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 1.8 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.6 | 1.8 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.6 | 5.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 1.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.6 | 3.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 5.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 8.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.6 | 6.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.6 | 4.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 5.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 11.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 2.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.6 | 9.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.6 | 1.7 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
0.6 | 1.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 12.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.5 | 1.6 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
0.5 | 2.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 5.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.5 | 4.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 2.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.5 | 3.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.5 | 2.1 | GO:0004335 | galactokinase activity(GO:0004335) |
0.5 | 17.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.5 | 4.1 | GO:0005186 | pheromone activity(GO:0005186) |
0.5 | 4.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.5 | 3.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.5 | 3.5 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.5 | 1.0 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.5 | 4.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 10.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.5 | 2.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.5 | 4.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 2.4 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.5 | 79.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 3.8 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.5 | 1.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 1.9 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.5 | 1.4 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.5 | 1.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.5 | 1.8 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.5 | 3.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.5 | 2.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.4 | 1.8 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.4 | 1.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.4 | 2.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 0.9 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.4 | 4.4 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 1.7 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.4 | 6.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 2.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 3.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 2.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.4 | 1.3 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.4 | 2.1 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.4 | 5.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.4 | 3.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 1.3 | GO:0001607 | neuromedin U receptor activity(GO:0001607) |
0.4 | 6.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.4 | 3.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 5.3 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 4.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.4 | 5.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 3.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 4.3 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.4 | 2.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 3.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.2 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.4 | 4.7 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.4 | 2.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 1.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.4 | 1.2 | GO:0051747 | cytosine C-5 DNA demethylase activity(GO:0051747) |
0.4 | 7.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) sulfate transmembrane transporter activity(GO:0015116) |
0.4 | 5.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.4 | 6.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 3.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.4 | 4.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 4.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 2.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.4 | 6.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.3 | 1.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.4 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 5.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 3.1 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.3 | 4.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 2.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 1.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 1.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.3 | 1.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.3 | 1.0 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.3 | 2.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.3 | 1.0 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.3 | 1.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.3 | 1.0 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.3 | 1.0 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.3 | 5.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 74.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 2.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.3 | 3.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 8.6 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.3 | 3.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 5.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.3 | 1.5 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.3 | 0.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.3 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 8.8 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.3 | 0.9 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.3 | 1.7 | GO:0043559 | insulin binding(GO:0043559) |
0.3 | 7.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.3 | 1.1 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.3 | 9.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.3 | 2.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.3 | 1.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 2.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 3.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 0.8 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.3 | 2.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 7.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 2.0 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 4.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 2.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 0.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 1.3 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.3 | 1.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 1.3 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 4.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.3 | 1.5 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 2.3 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.3 | 3.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.7 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.2 | 1.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.2 | 4.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 1.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 2.4 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.2 | 7.3 | GO:0017166 | vinculin binding(GO:0017166) |
0.2 | 1.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 1.4 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.2 | 1.2 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 1.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.2 | 0.7 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.2 | 1.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.7 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 0.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.2 | 5.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 1.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 4.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 2.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 5.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.8 | GO:0033797 | selenate reductase activity(GO:0033797) |
0.2 | 1.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 5.0 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 1.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 3.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 1.0 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 1.0 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.2 | 1.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 2.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.8 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 17.1 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.2 | 3.7 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 1.4 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.2 | 1.2 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.2 | 0.4 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 3.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 1.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.2 | 3.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 2.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 4.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 3.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 5.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 14.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.2 | 7.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 2.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 5.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.2 | 3.1 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.2 | 1.0 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.2 | 0.7 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.5 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.2 | 2.0 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 3.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 1.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 3.4 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 4.1 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 1.1 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 0.6 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.2 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 5.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 2.9 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 0.8 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 1.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 4.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 7.1 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 4.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 3.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.6 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 2.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 2.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.1 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.1 | 1.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 6.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 5.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 8.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 6.8 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.4 | GO:0004557 | alpha-galactosidase activity(GO:0004557) |
0.1 | 0.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 3.6 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 2.9 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 7.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.5 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 1.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 1.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.1 | 2.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 2.0 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 1.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.8 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 2.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 1.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.7 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.5 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 2.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 5.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.4 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 1.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 3.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 2.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.0 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 2.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 11.2 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 9.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 1.3 | GO:0004601 | peroxidase activity(GO:0004601) |
0.1 | 0.7 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 1.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.5 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 0.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 1.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 3.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.9 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 2.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.1 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 2.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 0.9 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 2.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 3.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 0.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 10.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 4.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 57.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 5.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 3.6 | GO:0035326 | enhancer binding(GO:0035326) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 1.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) L-malate dehydrogenase activity(GO:0030060) |
0.0 | 2.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 1.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.0 | 2.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.1 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.0 | 1.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.0 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.0 | 0.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.0 | 0.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0050997 | quaternary ammonium group binding(GO:0050997) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 1.2 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 42.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.5 | 12.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.5 | 16.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 22.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.4 | 22.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.3 | 16.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 4.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 76.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 7.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 9.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 8.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 2.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 11.6 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 5.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 8.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 1.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 22.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 5.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 4.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 5.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 4.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 2.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 3.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 10.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 2.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 2.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.6 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 72.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.8 | 25.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.4 | 24.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.3 | 14.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.1 | 18.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.1 | 3.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.9 | 13.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.9 | 17.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.9 | 14.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.9 | 6.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.8 | 9.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 15.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.8 | 13.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.8 | 21.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 25.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.7 | 13.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 2.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.7 | 27.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.7 | 7.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 127.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.6 | 48.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 13.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 8.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.6 | 10.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.6 | 11.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.5 | 23.9 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.5 | 17.2 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.5 | 19.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.5 | 10.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 9.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 7.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.4 | 27.9 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.4 | 0.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 3.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 4.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.3 | 22.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.3 | 7.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.3 | 5.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 23.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 7.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 9.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 3.4 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 0.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.3 | 2.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 5.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 13.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 2.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 2.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 4.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 5.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 3.9 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.2 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 1.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 3.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.2 | 10.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 4.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 3.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 1.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 7.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 17.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 12.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.7 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 3.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.2 | 2.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 1.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 8.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 1.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 4.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 2.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 3.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 3.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 3.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 2.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 0.1 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 2.4 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 5.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 4.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 2.7 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 2.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 2.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.9 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 1.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 3.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 3.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 1.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 3.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 3.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 1.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 1.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 1.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 0.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.4 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |